These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 217561)

  • 21. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
    Kwon KW
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of anti EBV antibodies in non-Hodgkin's lymphomams and angio-immunoblastic lymphadenopathies (author's transl)].
    Dumont J; Liabeuf A; Henle W; Ferchal F; Feingold N; Kourilsky FM
    Bull Cancer; 1979; 66(4):373-81. PubMed ID: 230873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma.
    Krueger GR; Manak M; Bourgeois N; Ablashi DV; Salahuddin SZ; Josephs SS; Buchbinder A; Gallo RC; Berthold F; Tesch H
    Anticancer Res; 1989; 9(6):1457-76. PubMed ID: 2560617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
    Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
    Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives.
    Besson C; Amiel C; Le-Pendeven C; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Abel L; Nicolas JC
    J Clin Microbiol; 2006 Jan; 44(1):47-50. PubMed ID: 16390946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epstein-Barr virus and its role in various rheumatic diseases].
    Anan'eva LP; Alekberova ZS; Barinskii IF; Nasonova VA
    Ter Arkh; 1983; 55(7):140-6. PubMed ID: 6312625
    [No Abstract]   [Full Text] [Related]  

  • 31. Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA).
    Lewin N; Aman P; Mellstedt H; Carenfelt C; Klein G; Klein E
    Anticancer Res; 1990; 10(5A):1213-6. PubMed ID: 2173472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma.
    Khan G; Lake A; Shield L; Freeland J; Andrew L; Alexander FE; Jackson R; Taylor PR; McCruden EA; Jarrett RF
    Br J Haematol; 2005 May; 129(4):511-9. PubMed ID: 15877733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epstein-Barr virus associated lymphocyte proliferation].
    Stein H; Hummel M; Anagnostopoulos I; Korbjuhn P; Niedobitek G; Dallenbach F; Herbst H
    Verh Dtsch Ges Pathol; 1992; 76():79-95. PubMed ID: 1283280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia.
    Berkel AI; Henle W; Henle G; Klein G; Ersoy F; Sanal O
    Clin Exp Immunol; 1979 Feb; 35(2):196-201. PubMed ID: 219976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
    Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I
    Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas.
    Besson C; Amiel C; Le-Pendeven C; Plancoulaine S; Bonnardel C; Ranque B; Abbed K; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Bresson JL; Nicolas JC; Gessain A; Dethe G; Abel L
    J Infect Dis; 2009 Apr; 199(8):1121-7. PubMed ID: 19284285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-associated lymphomas.
    Gandhi MK
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.